ozempic
1.0
Salivan4
1.67
12 reviews
1,000+
Downloads
Downloads
Free
ozempic your dedicated tool for seamless tracking
This app is currently not available on Google Play.
Try these apps instead
About ozempic
ozempic was a health & fitness app that used to be available on the Google Play store. It was developed
by Salivan4.
The APK had been available since December 2023.
ozempic was unpublished from the Google Play store Jun 4, 2024.
It was rated 1.67 out of 5 stars, based on 12 ratings. The last update of the app was on December 10, 2023. ozempic had a content rating "Everyone".
ozempic had an APK download size of 8.46 MB and the latest version available was 1.0. ozempic was FREE to download.
It was rated 1.67 out of 5 stars, based on 12 ratings. The last update of the app was on December 10, 2023. ozempic had a content rating "Everyone".
ozempic had an APK download size of 8.46 MB and the latest version available was 1.0. ozempic was FREE to download.
Description
More data about ozempic
Price | Free to download |
Total downloads | 1.6 thousand |
Rating | 1.67 based on 12 ratings |
Version | 1.0 |
APK size | 8.46 MB |
Number of libraries | ? |
Suitable for | Everyone |
Ads | NO ads |
Google Play Rating history and histogram
Downloads over time
ozempic has been downloaded 1.6 thousand times.
Changelog of ozempic
Developer information for Salivan4
Share and embed ozempic
EmbedComments on ozempic for Android
โ
โ
โโโ
This app is not the Olympic app that allows the seemless tracking. The website listed is a blank page running JavaScript and should be avoided. The official Olympic app has been removed from the Play store. This app is written to sell products that are not made by Olympic. The app is a copy cat, nothing to do with Olympic, and I've reported it to Google.
โ
โ
โโโ
I downloaded the app, and all I got was an advertisement for a supplement. Do not use.
โ
โ
โโโ
Just trying to sell random medications. Not a real app
Technologies used by ozempic
ozempic is requesting 31 permissions and we don't have library information (yet).Show details
Back to top